托桑聚硫酸黄斑病变:药物停用后疾病进展的4年前性研究的最终结果
Brian P Hall1, Sakshi Shiromani2, Emily H Jung3
1From the Emory University School of Medicine (B.P.H.), Atlanta, Georgia, USA.
American journal of ophthalmology
|December 12, 2024
概括
托桑聚硫酸盐 (PPS) 黄斑病变显示,在停止使用药物多年后,视力和视网膜结构持续下降. 这项研究强调了需要仔细处方和监测PPS来管理长期风险的必要性.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 托桑聚硫酸盐 (PPS) 是一种具有已知的眼部副作用的药物.
- PPS黄斑病是一种影响黄斑的疾病,可能导致视力丧失.
- 了解PPS停止的长期影响对于患者管理至关重要.
研究的目的:
- 为了研究药物停用后托桑多硫酸盐 (PPS) 黄斑病的长期疾病进展.
- 评估患者视觉功能和视网膜结构的变化PPS巨病后停止.
主要方法:
- 一个潜在的案例系列,涉及12名参与者 (23只眼睛) 被诊断为PPS巨病.
- 在四年内每年收集数据,评估视觉功能 (例如,BCVA,LLVA,微导测量,阅读性能) 和视网膜结构 (例如,cRORA,缩大小,CST,SFCT).
- 患者报告的结果使用验证的问卷进行评估 (NEI-VFQ-39,LLQ).
主要成果:
- 在四年内,观察到最佳校正视敏度 (BCVA) 和低亮度视敏度 (LLVA) 的显著下降.
- 阅读性能 (MNREAD) 和视野灵敏度 (微波测量) 的逐渐恶化发生.
- 在很大一部分眼睛中观察到完整的视网膜色素表皮和外视网膜缩 (cRORA) 的发展和扩张.
结论:
- 即使在药物戒断后,PPS黄斑病也会表现出持续的功能和结构缺陷.
- 这些发现强调了知情的处方,患者咨询和对PPS黄斑病的警监测的重要性.
- 对于接受托桑聚硫酸盐治疗的患者来说,长期随访是必不可少的.
相关概念视频
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:23Ophthalmic Drug Delivery Systems
284
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
284